Amaç: Kliniğimizde takip ve tedavi edilen erişkin anogenital verruka olgularının demografik, klinik, patolojik ve prognostik özelliklerini inceleyip ülkemize dair güncel verileri ortaya koyarak, değişken dinamikleri olan bu hastalığın yönetimine katkı sunmayı amaçladık. Gereç ve Yöntemler: Bu kesitsel çalışmada, polikliniğimizde 2015-2021 yılları arasında, anogenital verruka tanısıyla takip edilen 18 yaş ve üzeri 329 hastanın klinik ve epidemiyolojik verileri retrospektif olarak değerlendirilmiştir. Bulgular: Çalışmaya dâhil edilen 329 hastanın %78,4'ü erkek, %21,6'sı kadın, ortalama yaş 35,2 (± 12,1) medyan yaş 32 (aralık 18-7) idi. En çok hasta 124 (%37,7) hasta ile 18-30 yaş aralığında bulunmaktaydı. Hastaların %10'unda ekstragenital verruka tespit edildi. Hiçbir hastada insan bağışıklık yetersizliği virüsü testi pozitif bulunmazken, 1 hastada VDRL, 3 hastada hepatit B yüzey antijeni, 4 hastada anti-hepatit C virüsü pozitif olarak saptandı. Lezyonlarından histopatolojik inceleme yapılan 27 hastanın 19'unda verruka ile uyumlu bulgulara rastlanırken, 3 hastada displazi, 5 hastada neoplazi tespit edilmiştir. Bir yıllık düzenli tedavinin sonucunda, hastaların %74,2'sinde gözle görünür verruka lezyonu kalmazken, %2,7'sinde tedavilere direnç, %0,9'unda kısmi cevap, %21,6'sında ilk 1 yıl içinde rekürrens gözlenmiştir. Sonuç: Sağlık kuruluşlarına zamanında başvuru, uygun tedavinin erken dönemde düzenlenmesi, düzenli takip ile malignite gibi ciddi komplikasyonların yaratacağı morbidite ve mortalitenin azaltılabileceğine inanmaktayız.
Anahtar Kelimeler: İnsan papilloma virüs; anogenital verruka; epidemiyoloji
Objective: We aimed to contribute to the management of this disease with variable dynamics by examining the demographic, clinical, pathologic and prognostic features of the adult anogenital verruca cases followed and treated in our clinic, presenting current data for our country. Material and Methods: In this cross-sectional study, we retrospectively evaluated clinical and demographic data of 329 patients aged 18 years and older who were followed up with a diagnosis of anogenital verruca at our clinic between 2015 and 2021. Results: Of the 329 patients included in the study, 78.4% were male and 21.6% were female, with a mean age of 35.2 (± 12.1) and a median age of 32 (range 18-7). The majority of patients were between 18 and 30 years of age, with 124 (37.7%) patients. Extragenital verrucae were detected in 10% of the patients. There was no positive case of anti-human immunodeficiency virus, however, Venereal Disease Research Laboratory positivity in 1 patient, hepatitis B surface antigen positivity in 3 patients and antihepatitis C virus positivity in 4 patients were detected. Histopathologic examination was performed in 27 patients, verruca vulgaris was detected in 19 patients, dysplasia in 3 patients and neoplasia in 5 patients. After one year of regular treatment, 74.2% of patients had no visible verruca lesion, 2.7% were resistant to treatment, 0.9% had a partial response, and 21.6% had a recurrence within the first year. Conclusion: We believe that morbidity and mortality from serious complications such as malignancy can be reduced through timely presentation to healthcare facilities, early initiation of appropriate treatment, and regular follow-up.
Keywords: Human papillomavirus; anogenital wart; epidemiology
- Kirnbauer R, Lenz P. Human papillomaviruses. In: Bolognia JL, Schaffer JV, Cerroni L, eds. Dermatology. 4th ed. London: Saunders; 2018. p.1383-99.
- Brianti P, De Flammineis E, Mercuri SR. Review of HPV-related diseases and cancers. New Microbiol. 2017;40(2):80-5. [PubMed]
- Serrano B, Brotons M, Bosch FX, Bruni L. Epidemiology and burden of HPV-related disease. Best Pract Res Clin Obstet Gynaecol. 2018;47:14-26. [Crossref] [PubMed]
- Stanley MA, Sterling JC. Host responses to infection with human papillomavirus. Curr Probl Dermatol. 2014;45:58-74. [Crossref] [PubMed]
- Magalhães GM, Vieira ÉC, Garcia LC, De Carvalho-Leite MLR, Guedes ACM, Araújo MG. Update on human papilloma virus - part I: epidemiology, pathogenesis, and clinical spectrum. An Bras Dermatol. 2021;96(1):1-16. [Crossref] [PubMed] [PMC]
- Shanmugasundaram S, You J. Targeting persistent human papillomavirus infection. Viruses. 2017;9(8):229. [Crossref] [PubMed] [PMC]
- Gökşin Ş, İmren IG, Demirkan N, Duygulu Ş. Disseminated verrucae in a patient with rheumatoid arthritis: Abatacept effect on immunologic defense mechanism. Dermatol Ther. 2020;33(6):e14119. [Crossref] [PubMed]
- Salah E. Impact of multiple extragenital warts on quality of life in immune-competent Egyptian adults: a comparative cross-sectional study. Clin Cosmet Investig Dermatol. 2018;11:289-95. [Crossref] [PubMed] [PMC]
- Veasey JV, Framil VM, Nadal SR, Marta AC, Lellis RF. Genital warts: comparing clinical findings to dermatoscopic aspects, in vivo reflectance confocal features and histopathologic exam. An Bras Dermatol. 2014;89(1):137-40. [Crossref] [PubMed] [PMC]
- Patel H, Wagner M, Singhal P, Kothari S. Systematic review of the incidence and prevalence of genital warts. BMC Infect Dis. 2013;13:39. [Crossref] [PubMed] [PMC]
- Ozgul N, Tuncer M, Abacioglu M, Gultekin M. Estimating prevalence of genital warts in Turkey: survey among KETEM-affiliated gynecologists across Turkey. Asian Pac J Cancer Prev. 2011;12(9):2397-400. [PubMed]
- Ünal E, Gönül M, Çakmak S, Yalçınkaya Iyidal A, Kılıç A, Gül Ü, et al. Serological test results of sexually transmitted diseases in patients with condyloma acuminata. Postepy Dermatol Alergol. 2015;32(4):286-9. [Crossref] [PubMed] [PMC]
- Aktaş H, Ertuğrul G, Benli AR. Genital siğilli hastalarda cinsel yolla bulaşan diğer hastalıklara ait serolojik test sonuçları: retrospektif bir değerlendirme [Serological profile of other sexually transmitted diseases in patients with condyloma acuminata: a retrospective view]. Arch Clin Exp Med. 2017;2(1):15-7. [Crossref]
- Kaymak Y, Yüksel N, Ekşioglu M. Coincidence of condyloma accuminata with other sexually transmitted diseases. Turk Derm. 2004;38:48-53. [Link]
- Yılmaz B, Hat BN, Yürekli Y, Oskay Ü. Genç erişkinlerin human papilloma virüs (HPV) ve HPV aşısına ilişkin bilgi ve görüşleri: kesitsel bir çalışma [Knowledge and attitude of young adults on HPV infection and HPV vaccine: a cross-sectional study]. Kocaeli Üniversitesi Sağlık Bilimleri Dergisi. 2021;7(2):138-48. [Crossref]
- Goldstone SE, Giuliano AR, Palefsky JM, Lazcano-Ponce E, Penny ME, Cabello RE, et al. Efficacy, immunogenicity, and safety of a quadrivalent HPV vaccine in men: results of an open-label, long-term extension of a randomised, placebo-controlled, phase 3 trial. Lancet Infect Dis. 2022;22(3):413-25. [Crossref] [PubMed]
- Adeli M, Moghaddam-Banaem L, Shahali S. Sexual dysfunction in women with genital warts: a systematic review. BMC Womens Health. 2022;22(1):516. [Crossref] [PubMed] [PMC]
- Nia MH, Rahmanian F, Ghahartars M, Janghorban R. Sexual function and sexual quality of life in men with genital warts: a cross-sectional study. Reprod Health. 2022;19(1):102. [Crossref] [PubMed] [PMC]
- Qi SZ, Wang SM, Shi JF, Wang QQ, Chen XS, Sun LJ, Liu A, Zhang N, Jiang N, Siva P, Xu XL, Qiao YL. Human papillomavirus-related psychosocial impact of patients with genital warts in China: a hospital-based cross-sectional study. BMC Public Health. 2014;14:739. [Crossref] [PubMed] [PMC]
- Erdem Y, Özarmağan G. Genital siğilli hastalarda yaşam kalitesinin değerlendirilmesi [Evaluation of the quality of life in patients with genital warts]. Turkderm-Arch Turk Dermatol Venerology. 2016;50(1):21-4. [Crossref]
- Kaya İslamoğlu ZG, Ünal M, Özaslan M, Akyürek M, Sarı N. Çoklu ekstragenital siğillerin dermatoloji yaşam kalitesi üzerine etkisi: kesitsel bir çalışma [The effect of multiple extragenital warts on dermatology quality of life: a cross-sectional study]. Türkiye Klinikleri Dermatoloji Dergisi. 2019;29(2):64-8. [Crossref]
- Joly E, Desmoulin A, Tran PL, Derancourt C, Bertolotti A. Quality and consistency of clinical practice guidelines for the local management of anogenital warts: a systematic review using AGREE II score and RIGHT checklist. J Eur Acad Dermatol Venereol. 2023;37(4):e505-e7. [Crossref] [PubMed] [PMC]
- Das S, Yemul V, Deshmukh R. Incidence and association of HIV and other STDs in 200 persons belonging to a high risk group in central Mumbai. Venereology. 1998;11(1):19-23. [PubMed]
- Kowo M, Nzoume Nsope Mengang JM, Simeni Njonnou SR, Kouotou EA, Atangana PJA, Ankouane Andoulo F. Giant anogenital tumor of Buschke-Löwenstein in a patient living with human immunodeficiency virus/acquired immunodeficiency syndrome: a case report. J Med Case Rep. 2022;16(1):116. [Crossref] [PubMed] [PMC]
- Ghys PD, Diallo MO, Ettiègne-Traoré V, Yeboué KM, Gnaoré E, Lorougnon F, Kalé K, et al. Genital ulcers associated with human immunodeficiency virus-related immunosuppression in female sex workers in Abidjan, Ivory Coast. J Infect Dis. 1995;172(5):1371-4. [Crossref] [PubMed]
- Tosun S. Viral hepatitlerin ülkemizdeki değişen epidemiyolojisi [The changing viral hepatitis epidemiology in our country]. Ankem Derg. 2013;27(2):128-34. [Link]
- Simonart T, de Maertelaer V. Systemic treatments for cutaneous warts: a systematic review. J Dermatolog Treat. 2012;23(1):72-7. [Crossref] [PubMed]
- Lacey CJ, Woodhall SC, Wikstrom A, Ross J. 2012 European guideline for the management of anogenital warts. J Eur Acad Dermatol Venereol. 2013;27(3):e263-70. [Crossref] [PubMed]
- Nygård S, Nygård M, Orumaa M, Hansen BT. Quadrivalent HPV vaccine effectiveness against anogenital warts: a registry-based study of 2,2 million individuals. Vaccine. 2023;41(37):5469-76. Erratum in: Vaccine. 2023. [Crossref] [PubMed]
- Solmaz Hasdemir P. Vulvanın benign hastalıklarının tanı ve tedavisi [Diagnosis and management of the benign diseases of vulva]. Dicle Med J. 2019;46(4):889-95. [Crossref]
- Çetiner H, Kır G, Sakallı M, Karateke A. Zeynep Kamil Hastanesinde 2000-2006 yılları arasında tanı almış vulvar neoplaziler ve preneoplastik lezyonların dökümü [All vulvar neoplasms and preneoplastic lesions which were diagnosed in Zeynep Kamil Hospital between 2000-2006 year]. Marmara Med J. 2007;20(3):161-6. [Link]
.: Process List